Cefazolin (DrugBank: Cefazolin)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
291 | Hirschsprung disease, entire colon type | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03593252 (ClinicalTrials.gov) | September 1, 2018 | 22/5/2018 | Bowel Preparation in Elective Pediatric Intestinal Surgery | Mechanical Bowel Prep and Prophylactic Oral Antibiotic Use in Children: Implications for Intestinal Surgery Complications | Colostomy Stoma;Ileostomy - Stoma;Jejunostomy Stoma;Hirschprung's Disease;NEC;Inflammatory Bowel Diseases;Meconium Ileus;Bowel Obstruction | Drug: Senna;Drug: Sodium Picosulfate, Magnesium Oxide and Citric Acid;Drug: Erythromycin;Drug: Kanamycin;Drug: Cefazolin;Drug: Metronidazole;Other: Nil per os | McMaster University | NULL | Not yet recruiting | 6 Months | 18 Years | All | 48 | N/A | NULL |